CP and neoplasm: To further evaluate the tumor targeting ability of RBCm@AuNPs camouflaged by erythrocyte membrane in vivo, Cy5-labeled AuNPs-CP and RBCm@AuNPs were injected into B16-F10 tumor-bearing mice via the tail vein.